These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32224600)

  • 1. Reverse Remodeling and Current Medical Therapy in Heart Failure with Reduced Ejection Fraction.
    Maki H; Takeda N
    Int Heart J; 2020; 61(2):197-198. PubMed ID: 32224600
    [No Abstract]   [Full Text] [Related]  

  • 2. MY APPROACH to the patient with heart failure and improved ejection fraction
    Cohn JN
    Trends Cardiovasc Med; 2018 Feb; 28(2):153. PubMed ID: 29032935
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic Stalemate in Heart Failure With Preserved Ejection Fraction.
    Samson R; Le Jemtel TH
    J Am Heart Assoc; 2021 Jun; 10(12):e021120. PubMed ID: 34056916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New therapeutic options in congestive heart failure: Part I.
    McMurray J; Pfeffer MA
    Circulation; 2002 Apr; 105(17):2099-106. PubMed ID: 11980691
    [No Abstract]   [Full Text] [Related]  

  • 5. Left ventricular reverse remodeling in dilated cardiomyopathy- maintained subclinical myocardial systolic and diastolic dysfunction.
    Amorim S; Rodrigues J; Campelo M; Moura B; Martins E; Macedo F; Silva-Cardoso J; Maciel MJ
    Int J Cardiovasc Imaging; 2017 May; 33(5):605-613. PubMed ID: 28013418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction.
    Goldberg LR; Jessup M
    Circulation; 2006 Jun; 113(24):2851-60. PubMed ID: 16785351
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chronic Heart Failure With Preserved Ejection Fraction: Effective Treatment Possible?].
    Kanorskiy SG; Borisenko YV
    Kardiologiia; 2018 Jun; 58(6):85-89. PubMed ID: 30362441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polypill Eligibility for Patients with Heart Failure With Reduced Ejection Fraction in South India: A Secondary Analysis of a Prospective, Interrupted Time Series Study.
    Vijay A; Mohanan PP; Kondal D; Baldridge A; Davies D; Devarajan R; Unni G; Abdullakutty J; Natesan S; Joseph J; Jayagopal PB; Joseph S; Gopinath R; Prabhakaran D; Huffman MD; Agarwal A
    J Am Heart Assoc; 2021 Oct; 10(20):e021676. PubMed ID: 34612082
    [No Abstract]   [Full Text] [Related]  

  • 9. Mild systolic dysfunction in heart failure (left ventricular ejection fraction >35%): baseline characteristics, prognosis and response to therapy in the Vasodilator in Heart Failure Trials (V-HeFT).
    Carson P; Johnson G; Fletcher R; Cohn J
    J Am Coll Cardiol; 1996 Mar; 27(3):642-9. PubMed ID: 8606276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Cardiac Resynchronization Therapy on Cardiac Remodeling and Contractile Function: Results From Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE).
    St John Sutton M; Cerkvenik J; Borlaug BA; Daubert C; Gold MR; Ghio S; Chirinos JA; Linde C; Ky B
    J Am Heart Assoc; 2015 Sep; 4(9):e002054. PubMed ID: 26363005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction: the REversal of VEntricular Remodeling with Toprol-XL (REVERT) trial.
    Colucci WS; Kolias TJ; Adams KF; Armstrong WF; Ghali JK; Gottlieb SS; Greenberg B; Klibaner MI; Kukin ML; Sugg JE;
    Circulation; 2007 Jul; 116(1):49-56. PubMed ID: 17576868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart failure with preserved left ventricular ejection fraction: concepts, misconceptions and future directions.
    Soma J
    Blood Press; 2011 Jun; 20(3):129-33. PubMed ID: 21142436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heartbeat: Is there any effective therapy for heart failure with preserved ejection fraction?
    Otto CM
    Heart; 2018 Mar; 104(5):361-362. PubMed ID: 29440452
    [No Abstract]   [Full Text] [Related]  

  • 14. Left bundle branch block-induced left ventricular remodeling and its potential for reverse remodeling.
    Sze E; Daubert JP
    J Interv Card Electrophysiol; 2018 Aug; 52(3):343-352. PubMed ID: 30019271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized, double-blind, multicenter, placebo-controlled study evaluating the effect of aldosterone antagonism with eplerenone on ventricular remodeling in patients with mild-to-moderate heart failure and left ventricular systolic dysfunction.
    Udelson JE; Feldman AM; Greenberg B; Pitt B; Mukherjee R; Solomon HA; Konstam MA
    Circ Heart Fail; 2010 May; 3(3):347-53. PubMed ID: 20299607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting heart failure with preserved ejection fraction: current status and future prospects.
    Kanwar M; Walter C; Clarke M; Patarroyo-Aponte M
    Vasc Health Risk Manag; 2016; 12():129-41. PubMed ID: 27143907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New therapeutics for chronic heart failure.
    Mann DL; Deswal A; Bozkurt B; Torre-Amione G
    Annu Rev Med; 2002; 53():59-74. PubMed ID: 11818463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormones, drugs, remodeling and outcome in heart failure and after myocardial infarction.
    Cohn JN
    Cardiovasc Drugs Ther; 2001 Jan; 15(1):9-10. PubMed ID: 11504169
    [No Abstract]   [Full Text] [Related]  

  • 19. Improvement but no cure of left ventricular systolic dysfunction in treated heart failure patients.
    Murphy NF; O'Loughlin C; Ledwidge M; McCaffrey D; McDonald K
    Eur J Heart Fail; 2007 Dec; 9(12):1196-204. PubMed ID: 18039520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [How to evaluate and treat heart failure with preserved left ventricular ejection fraction].
    Cohen Solal A; Tournoux F; Beauvais F; Tartiere JM
    Therapie; 2009; 64(2):101-9. PubMed ID: 19664403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.